Leandro Grimaldi

Senior Director, Head of Strategy & Operations, Precision Amgen

Seminars

Thursday 5th February 2026
Rethinking Strategy: Moving Beyond Disease Stage with AI-Enabled Translational & Retrospective Drug Development
4:20 pm
  • Challenge traditional disease stage–focused development by adopting strategies that transcend indication silos
  • Explore how AI can act as a disruptive enabler to reimagine how translational data is collected, integrated, and applied
  • Demonstrate how these combined approaches can retrospectively inform new molecule design and accelerate the next generation of therapies
Leo Grimalid